<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02989610</url>
  </required_header>
  <id_info>
    <org_study_id>SJM-CIP-10061</org_study_id>
    <nct_id>NCT02989610</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Infinity DBS System</brief_title>
  <acronym>PROGRESS</acronym>
  <official_title>Post Market Clinical Follow Up Evaluating the Infinity Deep Brain Stimulation Implantable Pulse Generator System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this post market study is to support the chronic clinical performance of the
      Infinity Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG), DBS leads,
      extensions and related system components.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 31, 2017</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Therapeutic Window Evaluation</measure>
    <time_frame>3 month visit</time_frame>
    <description>The proportion of subjects with a therapeutic window (evaluated by a blinded evaluator) which is larger under directional stimulation than omnidirectional stimulation tested against a performance goal of 60% at the 3-month follow-up visit.</description>
  </primary_outcome>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Parkinson Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who have a diagnosis matching the approved indication and are being considered for
        a DBS implant or who have been implanted with an Infinity System comprise the target
        population for this study. All subjects who meet the inclusion and none of the exclusion
        criteria and have signed an Ethics Committee (EC) or Institutional Review Board (IRB)
        approved informed consent will be considered enrolled in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject is able to provide informed consent;

          -  Subjects diagnosed with Parkinson's disease (PD) and have been recommended to receive
             a DBS implant in the Subthalamic Nucleus (STN) or that have been implanted with an
             Infinity system in the STN;

          -  Subject must be available for follow-up visits.

        Exclusion Criteria:

          -  Subject is not a surgical candidate;

          -  In the Investigator's opinion the subject is unable to tolerate multiple programming
             sessions within a single setting;

          -  Subject is unable to comply with the follow up schedule.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfons Schnitzler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heinrich-Heine-Universität Düsseldorf, Institut für Klinische Neurowissenschaften und Medizinische Psychologie</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jan Vesper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heinrich-Heine-Universität Düsseldorf, Department of Functional Neurosurgery and Stereotaxy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DeLea Peichel</last_name>
    <phone>9723098094</phone>
    <email>dpeichel@sjm.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Traci Brooks</last_name>
    <phone>9723098505</phone>
    <email>tbrooks@sjm.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Vergen de Rocio</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Mir, MD</last_name>
      <phone>:+34-955923040</phone>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2016</study_first_submitted>
  <study_first_submitted_qc>December 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2016</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

